Company news

Orient Europharma Co., Ltd. (TPEX:4120) news

Orient Europharma Co., Ltd. news releases on 6ix. Latest, Feb 25, 2026: George Medicines advances its global commercial strategy for GMRx2 with an exclusive…

View Orient Europharma Co., Ltd. →

Press releases & updates

George Medicines advances its global commercial strategy for GMRx2 with an exclusive licensing agreement with Orient EuroPharma in Southeast Asia

February 25, 2026